Zhao Yingzi, Flavahan Sheila, Leung Susan W, Xu Aimin, Vanhoutte Paul M, Flavahan Nicholas A
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and.
Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H358-63. doi: 10.1152/ajpheart.00775.2014. Epub 2014 Dec 5.
Experiments were performed to determine whether or not acute exposure to elevated pressure would disrupt endothelium-dependent dilatation by increasing local angiotensin II (ANG II) signaling. Vasomotor responses of mouse-isolated carotid arteries were analyzed in a pressure myograph at a control transmural pressure (PTM) of 80 mmHg. Acetylcholine-induced dilatation was reduced by endothelial denudation or by inhibition of nitric oxide synthase (NG-nitro-L-arginine methyl ester, 100 μM). Transient exposure to elevated PTM (150 mmHg, 180 min) inhibited dilatation to acetylcholine but did not affect responses to the nitric oxide donor diethylamine NONOate. Elevated PTM also increased endothelial reactive oxygen species, and the pressure-induced endothelial dysfunction was prevented by the direct antioxidant and NADPH oxidase inhibitor apocynin (100 μM). The increase in endothelial reactive oxygen species in response to elevated PTM was reduced by the ANG II type 1 receptor (AT1R) antagonists losartan (3 μM) or valsartan (1 μM). Indeed, elevated PTM caused marked expression of angiotensinogen, the precursor of ANG II. Inhibition of ANG II signaling, by blocking angiotensin-converting enzyme (1 μM perindoprilat or 10 μM captopril) or blocking AT1Rs prevented the impaired response to acetylcholine in arteries exposed to 150 mmHg but did not affect dilatation to the muscarinic agonist in arteries maintained at 80 mmHg. After the inhibition of ANG II, elevated pressure no longer impaired endothelial dilatation. In arteries treated with perindoprilat to inhibit endogenous formation of the peptide, exogenous ANG II (0.3 μM, 180 min) inhibited dilatation to acetylcholine. Therefore, elevated pressure rapidly impairs endothelium-dependent dilatation by causing ANG expression and enabling ANG II-dependent activation of AT1Rs. These processes may contribute to the pathogenesis of hypertension-induced vascular dysfunction and organ injury.
进行实验以确定急性暴露于高压是否会通过增加局部血管紧张素II(ANG II)信号传导来破坏内皮依赖性舒张。在压力肌动描记仪中,于80 mmHg的对照跨壁压力(PTM)下分析小鼠离体颈动脉的血管舒缩反应。乙酰胆碱诱导的舒张可通过内皮剥脱或一氧化氮合酶抑制(NG-硝基-L-精氨酸甲酯,100 μM)而降低。短暂暴露于升高的PTM(150 mmHg,180分钟)会抑制对乙酰胆碱的舒张反应,但不影响对一氧化氮供体二乙胺NONOate的反应。升高的PTM还会增加内皮活性氧,而直接抗氧化剂和NADPH氧化酶抑制剂阿朴吗啡(100 μM)可预防压力诱导的内皮功能障碍。ANG II 1型受体(AT1R)拮抗剂氯沙坦(3 μM)或缬沙坦(1 μM)可降低升高的PTM引起的内皮活性氧增加。实际上,升高的PTM会导致ANG II前体血管紧张素原的明显表达。通过阻断血管紧张素转换酶(1 μM培哚普利拉或10 μM卡托普利)或阻断AT1R来抑制ANG II信号传导,可防止暴露于150 mmHg的动脉中对乙酰胆碱的反应受损,但不影响维持在80 mmHg的动脉中对毒蕈碱激动剂的舒张反应。抑制ANG II后,升高压力不再损害内皮舒张。在用培哚普利拉抑制该肽的内源性形成的动脉中,外源性ANG II(0.3 μM,180分钟)会抑制对乙酰胆碱的舒张反应。因此,升高的压力通过引起ANG表达并使AT1R依赖ANG II激活而迅速损害内皮依赖性舒张。这些过程可能有助于高血压诱导的血管功能障碍和器官损伤的发病机制。